This inventor holds 2 USPTO granted patents. Top assignees: Biocross Institute of Molecular Medicine (Nantong) Co., Ltd., Biomics Biotechnologies, Co., Ltd.. Active years: 2012-2016.
Company Filing History:
1 out of 1 
1 out of 7 Years Active: 2012-2016
Title: Innovations of Inventor Li Chen
Introduction
Li Chen is a notable inventor based in Nantong, China. He has made significant contributions to the field of molecular medicine, particularly in the design of therapeutic small ligand RNAs (sliRNAs). With a total of 2 patents, his work focuses on addressing diseases caused by pathological angiogenesis.
Latest Patents
Li Chen's latest patents include the "Application of highly conserved domain sequences from viral genome as template to design therapeutic sliRNAs." This invention relates to the application of highly conserved sequences of viral genomes, especially from a highly conserved domain of enteroviral genomes, as templates to design target small ligand RNAs (sliRNAs). The resulting sliRNAs serve as therapeutically active ingredients in the treatment of related diseases.
Career Highlights
Throughout his career, Li Chen has worked with prominent organizations such as Biocross Institute of Molecular Medicine Co., Ltd. and Biomics Biotechnologies Co., Ltd. His expertise in molecular medicine has positioned him as a key figure in the development of innovative therapeutic solutions.
Collaborations
Li Chen has collaborated with several professionals in his field, including Tiejun Li and YiXiang Lu, who is a woman. These collaborations have further enhanced his research and development efforts.
Conclusion
Li Chen's contributions to the field of molecular medicine through his innovative patents and collaborations highlight his commitment to advancing therapeutic solutions. His work continues to impact the treatment of diseases related to pathological angiogenesis.